The neuro-immune axis: Prospect for novel treatments for mental disorders

Files

Access status: Embargo until 2050-01-01 , bcpt12154.pdf (192.23 KB)

Publication date

2014-01-01

Authors

Kraneveld, Aletta D.ISNI 000000038803088X
de Theije, C.G.M.ISNI 0000000387317838
van Heesch, F.ISNI 0000000390598466
Borre, Y.E.ISNI 000000038853392X
de Kivit, S.ISNI 0000000419455515
Olivier, BerendISNI 0000000116225595
Korte, MechielISNI 000000039275977X
Garssen, J.ORCID 0000-0002-8678-9182ISNI 0000000034097251

Editors

Advisors

Supervisors

Document Type

Article

License

Abstract

Disturbed bidirectional pathways between the (central) nervous system and immune system have been implicated in various mental disorders, including depressive and neurodevelopmental disorders. In this minireview, the role of the neuro-immune axis and its targetability in relation to major depression and autism spectrum disorder will be discussed. All together, the management of these and possibly other multi-factorial mental disorders needs a new and integrated therapeutic approach. Pharmacologically bioactive molecules as well as medical nutrition targeting the (gut)-immune-brain axis could be such an approach. © 2013 Nordic Pharmacological Society.

Keywords

acetylcholine, adrenalin, alpha interferon, antibody, brain derived neurotrophic factor, bungarotoxin receptor, corticosteroid, immunomodulating agent, interleukin 1beta, interleukin 6, nerve growth factor, neuropeptide, neurotransmitter, nicotinic receptor, noradrenalin, serotonin transporter, toll like receptor 4, transforming growth factor beta, tumor necrosis factor alpha, astrocyte, autism, B lymphocyte, blood brain barrier, central nervous system, clinical trial (topic), cognitive defect, cytokine production, dendritic cell, efferent nerve, eosinophil, food aversion, granulocyte, human, hypothalamus hypophysis adrenal system, inflammatory disease, innate immunity, intestine flora, intracellular signaling, leukocyte, lymphocyte, macrophage, major depression, mast cell, meta analysis (topic), microglia, mononuclear phagocyte, nervous system inflammation, neuroimmunology, neurologic disease, nonhuman, nucleus accumbens, pain receptor, prefrontal cortex, priority journal, review, sensory nerve, social interaction, T lymphocyte, SDG 3 - Good Health and Well-being

Citation

Kraneveld, A D, de Theije, C G M, van Heesch, F, Borre, Y, de Kivit, S, Olivier, B, Korte, M & Garssen, J 2014, 'The neuro-immune axis: Prospect for novel treatments for mental disorders', Basic & Clinical Pharmacology & Toxicology, vol. 114, no. 1, pp. 128-136. https://doi.org/10.1111/bcpt.12154